Skip to main navigation Skip to search Skip to main content

Estrogen therapy in Turner syndrome: Does the type, dose and mode of delivery matter?

  • Alfred I. duPont Hospital for Children
  • University of Virginia

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

The best type, dose and route of estrogen replacement in hypogonadal females has not been fully elucidated and is the subject of this brief review. When feminizing girls with different forms of hypogonadism micronized 17BE 2 should be considered the first choice as it is the most physiological and can be accurately measured in plasma. Most studies of the metabolic effects of the different routes have also used different types of estrogen making comparisons difficult. However, when using the same estradiol compound, 17BE2 transdermal results in E2, E1 and bioestrogen concentrations closer to normal as compared to oral and achieves greater suppression of LHIFSH but similar IGF-I and lipid concentrations. Whether this translates into better body composition and metabolic outcomes in girls with hypogonadism is being actively investigated and data will soon be available.

Original languageEnglish
Pages (from-to)718-722
Number of pages5
JournalPediatric Endocrinology Reviews
Volume9
Issue numberSUPPL. 2
StatePublished - May 2012

Keywords

  • (8): Estradiol
  • Estrone
  • Hypogonadism
  • IGF-I
  • Pharmacokinetics
  • Puberty
  • Transdermal
  • Turner syndrome

Fingerprint

Dive into the research topics of 'Estrogen therapy in Turner syndrome: Does the type, dose and mode of delivery matter?'. Together they form a unique fingerprint.

Cite this